Immunogenicity in Biosimilars: Why Immune Responses May Differ from Reference Biologics
Biosimilars aren't exact copies of biologics-tiny structural differences can trigger immune responses in some patients. Learn why immunogenicity matters, how it's measured, and what real-world data shows about ADA risks.
Read more
